Inactive Instrument

News Entest BioMedical Inc. Other OTC

Equities

US29383T1025

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
2019	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ENTEST : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20-01-21	AQ
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	20-01-21	CI
ENTEST GROUP, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	20-01-07	AQ
Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	19-12-20	CI
ENTEST : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	19-12-20	AQ
Entest Group, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	19-07-15	CI
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018	19-01-22	CI
Entest Group, Inc. Announces Management Changes	18-12-03	CI
Peiwen Yu completed the acquisition of 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust.	18-11-26	CI
Peiwen Yu entered into an agreement to acquire 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust for $0.33 million.	18-11-19	CI
Entest Group, Inc. : Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.	18-05-10	PR
ENTB will Change its Name to ETNI	18-02-14	CI
Entest Biomedical : Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board	17-09-13	PR
Entest BioMedical : Settles $841,531 of Principal Indebtedness Through the Issuance of Equity Securities	17-05-31	PR
Entest Group, Inc. Auditor Raises 'Going Concern' Doubt	15-11-26	CI
Entest Biomedical, Inc. will Change its Ticker to ENTB from ENTB.D	15-08-21	CI
Entest Biomedical, Inc. will Change its Ticker to ENTBD from ENTB	15-07-27	CI
Christine Ichim Joins Entest BioMedical Inc. as Director of Research	14-07-16	CI
Entest Biomedical Mulls Acquisitions	13-03-06	CI
Entest Biomedical, Inc. Announces the Research Study Conducted on ImenVax(TM)	12-09-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Entest BioMedical Inc. Other OTC

Equities

US29383T1025

Summary

Filters